000			01325 a2200385 4500
005			20250514162845.0
264		0	_c20040630
008			200406s 0 0 eng d
022			_a0309-0167
024	7		_a10.1046/j.1365-2559.2003.01732.x _2doi
040			_aNLM _beng _cNLM
100	1		_aThiele, J
245	0	0	_aBone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis. _h[electronic resource]
260			_bHistopathology _cNov 2003
300			_a470-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBone Marrow _xdrug effects
650	0	4	_aBusulfan _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHematopoiesis _xdrug effects
650	0	4	_aHumans
650	0	4	_aHydroxyurea _xtherapeutic use
650	0	4	_aInterferons _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrimary Myelofibrosis _xdrug therapy
650	0	4	_aRetrospective Studies
700	1		_aKvasnicka, H M
700	1		_aSchmitt-Graeff, A
700	1		_aDiehl, V
773	0		_tHistopathology _gvol. 43 _gno. 5 _gp. 470-9
856	4	0	_uhttps://doi.org/10.1046/j.1365-2559.2003.01732.x _zAvailable from publisher's website
999			_c14372343 _d14372343